Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries.
Romero-Ibarguengoitia ME, González-Cantú A, Pozzi C, Levi R, Mollura M, Sarti R, Sanz-Sánchez MÁ, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, Del Rio-Parra GF, Barco-Flores IA, González-Facio R, Azzolini E, Barbieri R, de Azevedo Dias AR, Henriques Guimarães Júnior M, Bastos-Borges A, Acciardi C, Paez-Bo G, Teixeira MM, Rescigno M. Romero-Ibarguengoitia ME, et al. Among authors: hernandez ruiz yg. Front Immunol. 2022 Jul 28;13:894277. doi: 10.3389/fimmu.2022.894277. eCollection 2022. Front Immunol. 2022. PMID: 35967368 Free PMC article.
Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers.
Romero-Ibarguengoitia ME, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, González-Cantú A, Barco-Flores IA, González-Facio R, Montelongo-Cruz LP, Del Rio-Parra GF, Sanz-Sánchez MÁ. Romero-Ibarguengoitia ME, et al. Among authors: hernandez ruiz yg. Vaccines (Basel). 2022 Mar 3;10(3):392. doi: 10.3390/vaccines10030392. Vaccines (Basel). 2022. PMID: 35335024 Free PMC article.
Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico.
Romero-Ibarguengoitia ME, Rivera-Salinas D, Sarti R, Levi R, Mollura M, Garza-Silva A, Rivera-Cavazos A, Hernández-Ruíz YG, Barco-Flores IA, González-Cantú A, Sanz-Sánchez MÁ, Guimarães Júnior MH, Pozzi C, Barbieri R, Morales-Rodriguez DP, Texeira MM, Rescigno M. Romero-Ibarguengoitia ME, et al. Among authors: hernandez ruiz yg. Vaccines (Basel). 2023 Apr 14;11(4):842. doi: 10.3390/vaccines11040842. Vaccines (Basel). 2023. PMID: 37112754 Free PMC article.
Clinical characteristics of pediatric patients with confirmed SARS-CoV-2 infection who followed rigorous measures during two years of the COVID-19 pandemic in a hospital in Mexico.
Ramírez-Cázares AC, Hernández-Ruíz YG, Martínez-Longoria CA, Tamez-Gómez CE, Medina-Macías O, Treviño-Montalvo RG. Ramírez-Cázares AC, et al. Among authors: hernandez ruiz yg. Front Pediatr. 2023 Jun 27;11:1150738. doi: 10.3389/fped.2023.1150738. eCollection 2023. Front Pediatr. 2023. PMID: 37441570 Free PMC article.
Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.
Romero-Ibarguengoitia ME, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, González-Cantú A, Barco-Flores IA, González-Facio R, Montelongo-Cruz LP, Del Rio-Parra GF, Garza-Herrera MR, Leal-Meléndez JA, Sanz-Sánchez MÁ. Romero-Ibarguengoitia ME, et al. Among authors: hernandez ruiz yg. PLoS One. 2022 Mar 2;17(3):e0263942. doi: 10.1371/journal.pone.0263942. eCollection 2022. PLoS One. 2022. PMID: 35235587 Free PMC article.
Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study.
Romero-Ibarguengoitia ME, González-Cantú A, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, Barco-Flores IA, González-Facio R, Sanz-Sánchez MÁ. Romero-Ibarguengoitia ME, et al. Among authors: hernandez ruiz yg. Vaccines (Basel). 2022 Jul 17;10(7):1139. doi: 10.3390/vaccines10071139. Vaccines (Basel). 2022. PMID: 35891303 Free PMC article.
Risk factors for intubation and mortality in patients treated with high flow nasal cannula due to COVID-19 infection. Survival Analysis Study in a Northern Mexican Population.
Luviano-García JA, Loose-Esparza A, Hernández-Ruíz YG, Sanz-Sánchez MÁ, Maheda-García HJ, Sosa-Medellin MA, Garza-Silva A, Romero-Ibarguengoitia ME. Luviano-García JA, et al. Among authors: hernandez ruiz yg. PLoS One. 2024 Mar 15;19(3):e0296931. doi: 10.1371/journal.pone.0296931. eCollection 2024. PLoS One. 2024. PMID: 38489289 Free PMC article.